GPP
INFI

Great Point Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Great Point Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-625,000
Closed -$10.6M – 41
2014
Q4 		$10.6M Sell
625,000
-475,000
-43% -$6.92M 5.08% 6
2014
Q3 		$14.8M Buy
1,100,000
+141,400
+15% +$1.68M 6.34% 3
2014
Q2 		$12.2M Buy
958,600
+458,200
+92% +$4.77M 5.43% 5
2014
Q1 		$5.95M Buy
500,400
+49,300
+11% +$662K 3.11% 11
2013
Q4 		$6.23M Buy
+451,100
New +$6.37M 4.4% 7

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Great Point Partners's INFI Position: Q1 2015 in Review

Great Point Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2015, closing a stake of 625,000 shares — an estimated $10.6M sold.

Great Point Partners first reported a position in INFI in Q4 2013 and held it in 5 quarters. The position peaked at $14.8M in Q3 2014. 141 funds tracked by Wall St. Rank hold INFI as of Q1 2015.

  • Great Point Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Great Point Partners sold 625,000 Infinity Pharmaceuticals, Inc. shares in Q1 2015, an estimated $10.6M.
  • Great Point Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
  • Great Point Partners's Infinity Pharmaceuticals, Inc. position peaked at $14.8M in Q3 2014.
  • 141 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2015.

Based on Great Point Partners's 13F filing for Q1 2015, filed 15 May 2015.